Exploring the Effects of Bone Marrow Mesenchymal Stem Cells on Amyloid Plaque Reduction in a Rat Model of Alzheimer's Disease

Annita Annita✉, Gusti Revilla, Hirowati Ali, Almurdi Almurdi
DOI: https://doi.org/10.25077/mka.v46.i6.p1036-1044.2023

Abstract

Objective: This study aimed to evaluate the therapeutic potential of Bone Marrow-derived Mesenchymal Stem Cells (BM-MSCs) in mitigating amyloid plaque formation in Alzheimer's disease induced by Aluminum Chloride (AlCl3) in rats. Methods: Rats were divided into three groups: negative control, positive control (AlCl3-induced), and treatment (AlCl3 + BM-MSCs). Cognitive function was assessed five days post-induction, and amyloid plaques were quantified using Congo Red staining in the cortex and hippocampus. Results: A significant reduction in amyloid plaque was observed in rats treated with BM-MSCs. The proportion of stained areas decreased from 1.88 to 1.73 in the cortex and from 1.61 to 1.47 in the hippocampus, compared to AlCl3-only controls. Conclusion: BM-MSCs demonstrated a moderate but statistically significant reduction in amyloid plaque in a rat model of Alzheimer's disease, indicating their therapeutic potential.

Keywords

Mesenchymal Stem Cells; Neurodegenerative Diseases; Aluminum Chloride; Congo Red; Amyloid

Full Text:

PDF

References

Folch J PD, Ettcheto M, Abad S, Sánchez-López E, García ML, Olloquequi J, Beas-Zarate C, Auladell C, Camins A. Current Research Therapeutic Strategies for Alzheimer's Disease Treatment. . Neural Plast. 2016;2016.

Hernández AE GE. Mesenchymal Stem Cell Therapy for Alzheimer's Disease. 2021.

Duan Y LL, Zhan S. Stem Cell Therapy for Alzheimer's Disease: A Scoping Review for 2017-2022. Biomedicines. 2023;11(1):120.

Guide for the Care and Use of Laboratory Animals, 8th edition. Washington (DC): National Academies Press (US); 2011.

Yarni SD. Pengaruh Pemberian Mesenchymal Stem Cells Wharton Jelly Terhadap Ekspresi Gen CALM1 dan CASP9 Pada Tikus Alzheimer. Indonesia: Andalas University; 2021.

Maria Borowski MG-D, Lan Ji, Meng-Jiao Shi, Kelly P Smith, and Joseph Laning. Basic pluripotent stem cell culture protocols: Cambridge (MA): Harvard Stem Cell Institute; 2012.

Kraeuter AK GP, Sarnyai Z. . The Y-Maze for Assessment of Spatial Working and Reference Memory in Mice. . Methods Mol Biol. 2019;1916:105-11.

Yakupova EI BL, Vikhlyantsev IM, Bobylev AG. Congo Red and amyloids: history and relationship. Biosci Rep. 2019;39(1).

Mashhouri S, Froushani SMA, Tehrani AA. Non-Adherent Bone Marrow-Derived Mesenchymal Stem Cells Ameliorate Clinical Manifestations and Inflammation in an Experimental Model of Ulcerative Colitis in Rats. Iranian Journal of Medical Sciences. 2020;45(5):341-51.

Naadijk Y, Jager C, Fabian C, Leovsky C, Bluher A, Rudolph L, et al. Effect of systemic transplantation of bone marrow-derived mesenchymal stem cells on neuropathology markers in APP/PS1 Alzheimer mice. Neurapathol Appl Neurobiol. 2016;43(4):299-314.

Khan AA, Huat TJ, Mutery AA, El-Serafi AT, Kacem HH, Abdallah SH. Significant transcriptomic changes are associated with differentiation of bone marrow-derived mesenchymal stem cells into neural progenitor-like cells in the presence of bFGF and EG. Cell & Bioscience. 2020;10(126).

Ramezani M, Komaki A, Hashemi-Firouzi N, Mortezaee K, Faraji N, Golipoor Z. Therapeutic effects of melatonin-treated bone marrow mesenchymal stem cells (BMSC) in a rat model of Alzheimer’s disease. Journal of Chemical Neuroanatomy. 2020;108.

Wang Q, Yang Q, Wang Z, Tong H, Ma L, Zhang Y. Comparative analysis of human mesenchymal stem cells from fetal-bone marrow, adipose tissue, and Warton’s jelly as sources of cell

immunomodulatory therapy. Human Vaccines & Immunotherapeutics. 2016;12(1).

Salem AM, Ahmed HH, Atta HM, Ghazy MA, Aglan HA. Potential of bone marrow mesenchymal stem cells in management of Alzheimer’s disease in female rats. Cell Biology International. 2014;38(12):1367-83.

X W, G Y. Bone marrow mesenchymal stem cells-derived exosomes reduce Aβ deposition and improve cognitive function recovery in mice with Alzheimer's disease by activating sphingosine kinase/sphingosine-1-phosphate signaling pathway. Cell Biol Int. 2021;45(4):775-84.

Yu S, Hei Y, Liu W. Upregulation of seladin-1 and nestin expression in bone marrow mesenchymal stem cell transplantation via the ERK1/2 and PI3K/Akt signaling pathways in an Alzheimer's disease model. Oncology Letters. 2018;15(5):7443-9.

Qin C, Lu Y, Wang K, Bai L, Shi G, Huang Y, et al. Transplantation of bone marrow mesenchymal stem cells improves cognitive deficits and alleviates neuropathology in animal models of Alzheimer’s disease: a meta-analytic review on potential mechanisms. Translational Neurodegeneration. 2020;9(20).

Kruminis-Kaszkiel E, Osowski A, Bejer-Olenska E, Dziekonski M, Wojtkiewicz J. Differentiation of Human Mesenchymal Stem Cells from Wharton’s Jelly Towards Neural Stem Cells Using a Feasible and Repeatable Protocol. Cells. 2020;9(3).

Ayoub S, Berberi A, Fayyad-Kazan M. An update on human periapical cyst-mesenchymal stem cells and their potential applications in regenerative medicine. Molecular Biology Reports. 2020;47(3):2381-9.

Estakhri F, Panjehshahin MR, Tanideh N, Gheisari R, Azarpira N, Gholijani N. Efficacy of Combination Therapy with Apigenin and Synovial Membrane-Derived Mesenchymal Stem Cells on Knee Joint Osteoarthritis in a Rat Model. Iranian Journal of Medical Sciences. 2021;46(383-394).

Luo Y, Coskun, V., Liang, A., Yu, J., Cheng, L., Li, J. Single-cell transcriptome analyses reveal signals to activate dormant neural stem cells. Cell. 2021;161(5):1175-86.

Alvites R, Branquinho M, Sousa AC, Lopes B, Sousa P, Mauricio AC. Mesenchymal Stem/Stromal Cells and Their Paracrine Activity—Immunomodulation Mechanisms and How to Influence the Therapeutic Potential. Pharmaceutics. 2022;14(2).



Bookmark and Share
-->